Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Love

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Heart (British Cardiac Society)|February 1, 1997
Endothelin in heart failure: a promising therapeutic target?M P Love, J J McMurray
Basic Research in Cardiology|January 1, 1996
Endothelin in congestive heart failureM P Love, J J McMurray
Cardiovascular Research|May 1, 1996
Endothelin in chronic heart failure: current position and future prospectsM P Love, J J McMurray
Drugs & Aging|June 23, 2001
Endothelin receptor antagonists and cardiovascular diseases of agingM P Love, J J McMurray
Heart Failure Reviews|July 12, 2001
Clinical experience with endothelin receptor antagonists in chronic heart failureA Seed, M P Love, J J McMurray
Clinical Pharmacology and Therapeutics|May 29, 2000
Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failureA P Davie, M P Love, J J McMurray
Clinical Science (London, England : 1979)|December 22, 1999
Venous endothelin receptor function in patients with chronic heart failureM P Love, W G Haynes, D J Webb, et al.
European Journal of Heart Failure|August 11, 2000
Novel neuropeptides in the pathophysiology of heart failure: adrenomedullin and endothelin-1M C Petrie, S J McClure, M P Love, et al.
Circulation|November 1, 1996
Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitorsM P Love, W G Haynes, G A Gray, et al.
Clinical Science (London, England : 1979)|June 21, 2001
Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failureC Hillier, M C Petrie, M P Love, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Heart (British Cardiac Society)|February 1, 1997
Endothelin in heart failure: a promising therapeutic target?M P Love, J J McMurray
Basic Research in Cardiology|January 1, 1996
Endothelin in congestive heart failureM P Love, J J McMurray
Cardiovascular Research|May 1, 1996
Endothelin in chronic heart failure: current position and future prospectsM P Love, J J McMurray
Drugs & Aging|June 23, 2001
Endothelin receptor antagonists and cardiovascular diseases of agingM P Love, J J McMurray
Heart Failure Reviews|July 12, 2001
Clinical experience with endothelin receptor antagonists in chronic heart failureA Seed, M P Love, J J McMurray
Clinical Pharmacology and Therapeutics|May 29, 2000
Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failureA P Davie, M P Love, J J McMurray
Clinical Science (London, England : 1979)|December 22, 1999
Venous endothelin receptor function in patients with chronic heart failureM P Love, W G Haynes, D J Webb, et al.
European Journal of Heart Failure|August 11, 2000
Novel neuropeptides in the pathophysiology of heart failure: adrenomedullin and endothelin-1M C Petrie, S J McClure, M P Love, et al.
Circulation|November 1, 1996
Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitorsM P Love, W G Haynes, G A Gray, et al.
Clinical Science (London, England : 1979)|June 21, 2001
Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failureC Hillier, M C Petrie, M P Love, et al.
Pageof 2